课题基金 / 基金详情

Plasma Levels and Clinical Pharmacology of Antiepileptic Drugs in Children

Plasma Levels and Clinical Pharmacology of Antiepileptic Drugs in Children
儿童抗癫痫药物的血浆水平和临床药理学
批准号:
61570467
负责人:
MIURA Hisao
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1986
资助国家:
日本
项目状态:
已结题
起止时间:
1986 至 1988

项目摘要

项目成果

MIURA Hisao的其他基金

相似基金

相关文献

中文摘要
翻译
在过去的10年中,通过将药代动力学数据应用于癫痫的药物治疗,在癫痫的治疗中取得了较好的效果。本研究采用前瞻性随机对照研究方法,观察了苯妥英钠、卡马西平(CBz)、丙戊酸钠(VPA)单药治疗小儿癫痫发作时的血药浓度及控制癫痫发作的效果。对新转诊的、以前未经治疗的儿童的研究表明,这三种药物均可预防部分和全身强直-阵挛性痉挛。氯硝西泮(Clonazepan,CZP)对癫痫部分性发作可能有效。然而,由于广泛的血浆水平与癫痫发作完全无关,因此无法确定CZP的治疗范围。任何接受多种药物治疗的患者都有发生药物相互作用的风险。与CBZ剂量相比,VPA同时给药与卡马西平-10,11-eposiex(CBZ-E)(CBZ的主要代谢产物)的血浆水平升高相关,而血浆CBZ水平保持不变。CBZ-E的高血药浓度可能是导致某些患者出现副作用的原因,药物与蛋白质的相互作用也是引起副作用的原因之一。CBZ和CBZ-E联合用药组血浆中CBZ和CBZ-E的游离或无蛋白水平均显著高于CBZ单药组,了解CBZ和CBZ-E的药代动力学规律是指导儿童抗癫痫药物治疗的重要依据。
英文摘要
During the past 10 years, better results in the treatment of epilepsy have been obtained through the application of pharmacokinetic data to drug therapy of epilepsy. However, pediatric drug therapy is complicated by the continuous change in body weight and body composition with the growth and development.The plasma levels and seizure control were investigated in a prospective randomized stury when phenytion, carbamazepine (CBz) or sodium valproate (VPA) was given as a single drug to pediatric patients with several types of epileptic seizures. Studies on newly referred, previously untreated children suggest that both partial and generalized tonic-clonic seizured can be prevented by each of the three drugs. No significant differences in clinical efficacy were found between the three drugs, when optimum plasma concentration ranges were maintained with blood level monitoring.Clonazepan (CZP) may be effective in partial seizures. However, as a wide range of plasma levels was associated with complete freedom from seizures, it was not possible to define a therageutic range for CZP.Any patient who receives multiple-drug therapy is at risk to develop a drug-drug interaction. Simultaneous administration of VPA was associated with a raised plasma level of carbamazepine-10,11-eposiex (CBZ-E), a major metabolite of CBZ, relative to the CBZ dose, whereas the plasma CBZ level remained unaltered. The high plasma concentration of CBZ-E may be responsible for the side-effects in some patients.Drug-protein binding interactions are another source of side-effects. The unbound or protein-free plasma levels of both CBZ and CBZ-E in patients treated with CBZ and VPA were significantly higher than those in patients treated with CBZ alone.A working knowledge of the pharmacokinetic principles is an important basis for treating children with antiepileptic drugs.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
三浦寿男: てんかん研究. 5. 41-49 (1987)
三浦久雄:癫痫研究。5. 41-49 (1987)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
白井宏幸: TDM研究. 4. (2 ) (1987)
白井宏之:TDM 研究 4. (2) (1987)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
三浦寿男: 小児科. 27. 769-775 (1986)
三浦久夫:儿科。27. 769-775 (1986)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 31 条
    Developmental Pharmacology and Therapeutic Drug Monitoring of Antiepileptic Drugs
    • 批准号:
      09670832
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.66万
    • 财政年份:
      1997
    • 负责人:
      MIURA Hisao
    • 依托单位:
    Developmental and Therapeutic Pharmacology of Antiepileptic Drugs
    • 批准号:
      05670696
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1993
    • 负责人:
      MIURA Hisao
    • 依托单位:
    Developmental and Therapeutic Pharmacology of Antiepileptic Drugs
    • 批准号:
      02670459
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.54万
    • 财政年份:
      1990
    • 负责人:
      MIURA Hisao
    • 依托单位:
    海外基金